Ensayo clínico

Strategy TO Prevent Decompensated Heart Failure

NCT: NCT06641921 · COMPLETED

ID NCTNCT06641921

EstadoCOMPLETED

Fecha de inicio2024-05-01

Finalización2026-05-01

SponsorSeerlinq s. r. o. (OTHER)

First posted2024-10-15

Last updated2026-10-07

Resumen breve

The goal of this prospective, multicenter, single-arm, open-label clinical trial (Strategy TO Prevent Decompensated Heart Failure) is to evaluate the 12-month incidence of heart failure hospitalization (HFH) and all cause mortality in patients managed with haemodynamically guided treatment using the Seerlinq telemedical monitoring system.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.